Pharmacist's Letter

211 - 225 of 247 Results

Sort Results:

Other: SAMPLE Informed Consent Form for Quinine from Prescriber's Letter June 2010

Article: concerns about whether antidepressants can increase the risk for stroke, heart disease, or death February 2010

Guideline: Practice Guideline for the Treatment of Patients with Major Depressive Disorder (2010) February 2010

Guideline: Depression and Coronary Disease: Screening, Referral, and Treatment February 2010

Commentary: Antidepressants and Cardiovascular Risk February 2010

Guideline: 2008 ADA Consensus Statement on Management of Hyperglycemia in Type 2 Diabetes December 2008

Commentary: Beta-Blockers for Hypertension: Help or Harm? December 2008

Commentary: Updated Treatment Recommendations for Type 2 Diabetes December 2008

Article: The ADA is dropping its recommendation for Avandia and now recommends a back-to-basics approach for treating type 2 diabetes December 2008

Article: Do beta-blockers INCREASE mortality when used for hypertension December 2008

Article: whether inhaled tiotropium and ipratropium increase stroke, heart attack, and death in COPD patients November 2008

Guideline: AAP Policy Statement on Cardiovascular Monitoring and Stimulant Drugs for ADHD (Addendum May 2008: On May 28, 2008, the American Academy of Pediatrics (AAP) released a statement on cardiovascular monitoring in children and adolescents taking ADHD medications. The AAP does not recommend screening ECGs unless the patient's history, family history, or the physical examination raises concerns.) June 2008

Guideline: Cardiovascular Monitoring of Children and Adolescents With Heart Disease Receiving Stimulant Drugs (2008) June 2008

Guideline: Cardiovascular Monitoring of Children and Adolescents With Heart Disease Receiving Stimulant Drugs (Correction) (2009) June 2008

Commentary: Cardiovascular Screening and Monitoring Of Children and Adolescents Receiving ADHD Drugs June 2008